All Stories

  1. Physiological Care of the Organ Donor
  2. 4Ps framework: practical actions to protect individual health in the current climate crisis
  3. Respiratory viral infections awaken metastatic breast cancer cells in lungs
  4. The ‘climate emergency’, and how we respond
  5. Respiratory viral infection promotes the awakening and outgrowth of dormant metastatic breast cancer cells in lungs
  6. Cardiovascular assessment for non-cardiac surgery: abridgement of updated European guidelines
  7. Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial
  8. Totality of evidence of the effectiveness of repurposed therapies for COVID‐19: Can we use real‐world studies alongside randomized controlled trials?
  9. Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways)
  10. Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
  11. Cardiopulmonary exercise testing before and after intravenous iron in preoperative patients: a prospective clinical study
  12. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
  13. Effect of different levels of acute hypoxia on subsequent oral glucose tolerance in males with overweight: A balanced cross‐over pilot feasibility study
  14. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study
  15. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
  16. Learning to treat the climate emergency together: social tipping interventions by the health community
  17. Peripheral sensory function in non‐freezing cold injury patients and matched controls
  18. Plasma biomarkers of endothelial function, inflammation and oxidative stress in individuals with non‐freezing cold injury
  19. The peripheral vascular responses in non‐freezing cold injury and matched controls
  20. Climate change threatens our health and survival within decades
  21. Cardiac and vascular serious adverse events following tixagevimab–cilgavimab – Author's reply
  22. STIMULATE-ICP-Delphi study to inform integrated care pathways for Long COVID.
  23. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression
  24. The 2022 report of the Lancet Countdown on health and climate change: health at the mercy of fossil fuels
  25. Global environmental climate change, covid-19, and conflict threaten food security and nutrition
  26. Population history and genome wide association studies of birth weight in a native high altitude Ladakhi population
  27. Climate change, healthy ageing and the health crisis: is wisdom the link?
  28. STIMULATE-ICP-CAREINEQUAL (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways) study protocol: Defining usual care and examining inequalities in Long Covid support
  29. Safety and Feasibility Assessment of Repetitive Vascular Occlusion Stimulus (RVOS) Application to Multi-Organ Failure Critically Ill Patients: A Pilot Randomised Controlled Trial
  30. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
  31. Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
  32. Senior health professionals call for urgent climate briefing of all MPs by the chief scientific adviser: open letter to PM
  33. Travelling back to normal
  34. Whole-genome sequencing reveals host factors underlying critical COVID-19
  35. AlzEye: longitudinal record-level linkage of ophthalmic imaging and hospital admissions of 353 157 patients in London, UK
  36. Maintenance of Serum Potassium Levels ≥3.6 mEq/L Versus ≥4.5 mEq/L After Isolated Elective Coronary Artery Bypass Grafting and the Incidence of New-Onset Atrial Fibrillation: Pilot and Feasibility Study Results
  37. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  38. Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research
  39. The attitude of patients with progressive ataxias towards clinical trials
  40. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  41. Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
  42. The experience of drowning
  43. Principles of environmentally‐sustainable anaesthesia: a global consensus statement from the World Federation of Societies of Anaesthesiologists
  44. ACSM Expert Consensus Statement: Injury Prevention and Exercise Performance during Cold-Weather Exercise
  45. Who cares about climate?
  46. The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  47. Digital and technological innovation in vector-borne disease surveillance to predict, detect, and control climate-driven outbreaks
  48. Should we treat COVID‐19 lung injury like ARDS? Exploring the paradigm
  49. Selection pressure at altitude for genes related to alcohol metabolism: A role for endogenous enteric ethanol synthesis?
  50. Effect of intermittent or continuous feeding and amino acid concentration on urea‐to‐creatinine ratio in critical illness
  51. Exergy intensity and environmental consequences of the medical face masks curtailing the COVID-19 pandemic: Malign bodyguard?
  52. Clinically Applicable Segmentation of Head and Neck Anatomy for Radiotherapy: Deep Learning Algorithm Development and Validation Study
  53. Mapping the human genetic architecture of COVID-19
  54. Multitask prediction of organ dysfunction in the intensive care unit using sequential subnetwork routing
  55. High-altitude population neonatal and maternal phenotypes associated with birthweight protection
  56. Use of deep learning to develop continuous-risk models for adverse event prediction from electronic health records
  57. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
  58. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  59. Physiological responses during ascent to high altitude and the incidence of acute mountain sickness
  60. Malnutrition risk in hospitalised COVID-19 patients receiving CPAP
  61. Intensive care physicians’ perceptions of the diagnosis & management of patients with acute hypoxic respiratory failure associated with COVID-19: A UK based survey
  62. Dysnatremia is a Predictor for Morbidity and Mortality in Hospitalized Patients with COVID-19
  63. The post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part I: Development and preliminary clinimetric evaluation
  64. The Post-ICU presentation screen (PICUPS) and rehabilitation prescription (RP) for intensive care survivors part II: Clinical engagement and future directions for the national Post-Intensive care Rehabilitation Collaborative
  65. A carbon monoxide ‘single breath’ method to measure total haemoglobin mass: a feasibility study
  66. Genetic mechanisms of critical illness in Covid-19
  67. The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises
  68. Response
  69. In pursuit of the unicorn
  70. Healthcare Workers Bioresource: Study outline and baseline characteristics of a prospective healthcare worker cohort to study immune protection and pathogenesis in COVID-19
  71. Effect of Intermittent or Continuous Feed on Muscle Wasting in Critical Illness
  72. COVID-19: UK frontline intensivists' emerging learning
  73. Reply to letter ‘Ultrasound-guided infraclavicular cannulation of the subclavian vein – still an ongoing misconception’
  74. Thirst-guided participant-controlled intravenous fluid rehydration: a single blind, randomised crossover study
  75. Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management
  76. Application of the optimized carbon monoxide rebreathing method for the measurement of total haemoglobin mass in chronic liver disease
  77. Cannulation of the subclavian vein using real-time ultrasound guidance
  78. The 2019 report of The Lancet Countdown on health and climate change: ensuring that the health of a child born today is not defined by a changing climate
  79. Matters of life and death: Change beyond planetary homeostasis
  80. A clinically applicable approach to continuous prediction of future acute kidney injury
  81. Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions
  82. Repetitive vascular occlusion stimulus (RVOS) versus standard care to prevent muscle wasting in critically ill patients (ROSProx):a study protocol for a pilot randomised controlled trial
  83. Implementation of a Digitally Enabled Care Pathway (Part 2): Qualitative Analysis of Experiences of Health Care Professionals
  84. Implementation of a Digitally Enabled Care Pathway (Part 1): Impact on Clinical Outcomes and Associated Health Care Costs
  85. A multidisciplinary consensus on dehydration: definitions, diagnostic methods and clinical implications
  86. Diarrhoea in critical care is rarely infective in origin, associated with increased length of stay and higher mortality
  87. The Effectiveness of Unconventional Monetary Policy in Japan
  88. Metabolomic and lipidomic plasma profile changes in human participants ascending to Everest Base Camp
  89. Palaeoecological and genetic evidence for Neanderthal power locomotion as an adaptation to a woodland environment
  90. The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come
  91. The Smell of Hypoxia: using an electronic nose at altitude and proof of concept of its role in the prediction and diagnosis of acute mountain sickness
  92. Replicating measurements of total hemoglobin mass (tHb-mass) within a single day: precision of measurement; feasibility and safety of using oxygen to expedite carbon monoxide clearance
  93. Clinically applicable deep learning for diagnosis and referral in retinal disease
  94. Are Bank Mergers Good News for Shareholders? The Effect of Bank Mergers on Shareholder Value in Japan
  95. Metabolic phenotype of skeletal muscle in early critical illness
  96. Metabolic adjustment to high-altitude hypoxia: from genetic signals to physiological implications
  97. Letter in response to Google DeepMind and healthcare in an age of algorithms
  98. Eye care in the intensive care unit
  99. A practical guide to medical ethics for intensivists
  100. A practical guide to medical ethics for intensivists: Part 2
  101. The Lancet Countdown on health and climate change: from 25 years of inaction to a global transformation for public health
  102. Could patient-controlled thirst-driven fluid administration lead to more rapid rehydration than clinician-directed fluid management? An early feasibility study
  103. The sensitivity of the human thirst response to changes in plasma osmolality: a systematic review
  104. Non-freezing cold injury: a multi-faceted syndrome
  105. The impact of maintaining serum potassium ≥3.6 mEq/L vs ≥4.5 mEq/L on the incidence of new-onset atrial fibrillation in the first 120 hours after isolated elective coronary artery bypass grafting – study protocol for a randomised feasibility trial for ...
  106. Critical care at the end of life: balancing technology with compassion and agreeing when to stop
  107. Reducing sound and light exposure to improve sleep on the adult intensive care unit: An inclusive narrative review
  108. Tropical cyclones and public health: how climate change is driving increasingly extreme weather—an essay by Fintan Hughes, Jack Hodkinson, and Hugh Montgomery
  109. Does hypoxia play a role in the development of sarcopenia in humans? Mechanistic insights from the Caudwell Xtreme Everest Expedition
  110. Effect of Bank Mergers on Client Firms: Evidence from the Credit Supply Channel
  111. Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury
  112. The future of UK healthcare: problems and potential solutions to a system in crisis
  113. Service evaluation of the implementation of a digitally-enabled care pathway for the recognition and management of acute kidney injury
  114. Humanizing critical care
  115. Hemoglobin concentration, total hemoglobin mass and plasma volume in patients: implications for anemia
  116. Cardiovascular assessment for non-cardiac surgery: European guidelines
  117. Christiana Figueres joins The Lancet Countdown—delivering on the promise of Paris
  118. Metabolic basis to Sherpa altitude adaptation
  119. Late Anthracycline-Related Cardiotoxicity in Low-Risk Breast Cancer Patients
  120. Total haemoglobin mass, but not haemoglobin concentration, is associated with preoperative cardiopulmonary exercise testing-derived oxygen-consumption variables
  121. Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning
  122. ACE and response to pulmonary rehabilitation in COPD: two observational studies
  123. Preventing the progression of climate change: one drug or polypill?
  124. The Lancet Countdown: tracking progress on health and climate change
  125. The ‘Judicialization’ of International Commercial Arbitration: Pitfall or Virtue?
  126. Predictors of total morbidity burden on days 3, 5 and 8 after cardiac surgery
  127. Pre-operative anaemia is associated with total morbidity burden on days 3 and 5 after cardiac surgery: a cohort study
  128. Genetic structure in the Sherpa and neighboring Nepalese populations
  129. Rectus Femoris Cross-Sectional Area and Muscle Layer Thickness: Comparative Markers of Muscle Wasting and Weakness
  130. Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
  131. ESICM LIVES 2016: part three
  132. Applying machine learning to automated segmentation of head and neck tumour volumes and organs at risk on radiotherapy planning CT and MRI scans
  133. Automated analysis of retinal imaging using machine learning techniques for computer vision
  134. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  135. Angiotensin-Converting Enzyme Inhibition as an Adjunct to Pulmonary Rehabilitation in COPD
  136. An Exploratory Study of Long-Term Outcome Measures in Critical Illness Survivors
  137. Diarrhoea in the critically ill is common, associated with poor outcome and rarely due to Clostridium difficile
  138. The Great British Medalists Project: A Review of Current Knowledge on the Development of the World’s Best Sporting Talent
  139. A comparison of the quality of image acquisition between the incident dark field and sidestream dark field video-microscopes
  140. Caudwell Xtreme Everest: An Overview
  141. Genetic determinants of survival
  142. Genetic determinants of survival
  143. Athlome Project Consortium: a concerted effort to discover genomic and other “omic” markers of athletic performance
  144. Health and climate change: policy responses to protect public health
  145. Improving outcomes in patients with Acute Kidney Injury: the impact of hospital based automated AKI alerts
  146. Fasciitis frequently accompanies myopathy in acute critical illness muscle wasting: Evidence from qualitative ultrasound and muscle biopsy analysis
  147. Three years of Extreme Physiology & Medicine
  148. Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studies
  149. Qualitative Ultrasound in Acute Critical Illness Muscle Wasting
  150. Postoperative morbidity after surgical aortic valve replacement or transcatheter valve implantation: a prospective cohort study
  151. SP238AKI ALERTS: USING ADDITION OF SERUM BICARBONATE TO PREDICT OUTCOMES
  152. A pilot study of change in fracture risk in patients with acute respiratory distress syndrome
  153. Design and conduct of Xtreme Everest 2: An observational cohort study of Sherpa and lowlander responses to graduated hypobaric hypoxia
  154. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
  155. The Relationship Between Lower Limb Bone and Muscle in Military Recruits, Response to Physical Training and Influence of Smoking Status
  156. Genetic Factors Associated with Exercise Performance in Atmospheric Hypoxia
  157. The Effect of Renin Angiotensin System Genetic Variants in Acute Pancreatitis
  158. Oral Coenzyme Q10 Supplementation Does Not Prevent Cardiac Alterations During a High Altitude Trek to Everest Base Camp
  159. S141 Tumour Necrosis Factor Receptor 1 Shedding Is Related To Acute Skeletal Muscle Wasting In Critical Illness
  160. The economic consequences of the TARP: The effectiveness of bank recapitalization policies in the U.S.
  161. Trial of the Route of Early Nutritional Support in Critically Ill Adults
  162. A Randomized Controlled Trial of Angiotensin-Converting Enzyme Inhibition for Skeletal Muscle Dysfunction in COPD
  163. Pupil Dynamics in Hypoxic Conditions: Caudwell Xtreme Everest Results
  164. Too big to succeed? Banking sector consolidation and efficiency
  165. Reply to 'A note of caution about the excess winter deaths measure'
  166. How wasting is saving: Weight loss at altitude might result from an evolutionary adaptation
  167. Genome-Scale Methods Converge on Key Mitochondrial Genes for the Survival of Human Cardiomyocytes in Hypoxia
  168. Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress, Inflammation and Gluco-Insular Regulation: The Not-So-Sweet Price for Good Regulation
  169. Use of interferon beta for acute respiratory distress syndrome: proceed with caution – Authors' reply
  170. Climate change and human survival
  171. Climate warming will not decrease winter mortality
  172. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
  173. Children must be protected from the tobacco industry's marketing tactics
  174. S134 Activity monitoring in intensive care unit survivors: Assessing daily physical activity with objective outcome measures
  175. S54 Preservation of mitochondrial oxidative capacity in critically ill patients balances reduction in mitochondrial biogenesis
  176. Acute Skeletal Muscle Wasting in Critical Illness
  177. Climate change: the challenge for healthcare professionals
  178. Response to Letter About Article, "Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study"
  179. The Use of Skeletal Muscle Near Infrared Spectroscopy and a Vascular Occlusion Test at High Altitude
  180. No evidence for a local renin-angiotensin system in liver mitochondria
  181. Gender typing in stereotypes and evaluations of actual managers
  182. Surviving in a crevasse
  183. Genetic Signatures Reveal High-Altitude Adaptation in a Set of Ethiopian Populations
  184. Association Analysis of ACE and ACTN3 in Elite Caucasian and East Asian Swimmers
  185. Cerebral venous system and anatomical predisposition to high-altitude headache
  186. Tobacco industry lobbyists and their health-care clients
  187. Left Ventricular Wall Thickness and the Presence of Asymmetric Hypertrophy in Healthy Young Army Recruits: Data From the LARGE Heart Study
  188. Bone structure and geometry in young men: The influence of smoking, alcohol intake and physical activity
  189. Association between preoperative haemoglobin concentration and cardiopulmonary exercise variables: a multicentre study
  190. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome
  191. CMR shows that anthracycline cardiotoxicity is common in women treated for early breast cancer and associated with undiagnosed hypertension; but cannot be reliably detected using late-gadolinium enhancement imaging
  192. The breast cancer, early disease: toxicity from therapy with epirubicin regimens - cardiac assessment and risk evaluation (BETTER-CARE) study: CMR with early gadolinium relative enhancement, but not high-sensitivity troponin T, predicts the risk of chr...
  193. Conference, conscience and climate
  194. T3 Acute Muscle Loss in the Critically Ill: From Bedside to Bench
  195. S48 The Effect of Angiotensin-Converting Enzyme Inhibition on Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease: A Randomised Controlled Trial
  196. Cardiopulmonary exercise testing predicts postoperative outcome in patients undergoing gastric bypass surgery
  197. Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing
  198. Media reports fuelled by authors' claims
  199. Duration of preceding hypertension is associated with prolonged length of ICU stay
  200. Neuromuscular Blockade and Skeletal Muscle Weakness in Critically Ill Patients
  201. 018 The breast cancer, early disease: toxicity from therapy with epirubicin regimens ¨ c cardiac assessment and risk evaluation (better-care), cardiovascular magnetic resonance (CMR) sub-study: cycle 1 changes predict late anthracycline cardiotoxicity:...
  202. Closed and open breathing circuit function in healthy volunteers during exercise at Mount Everest base camp (5300 m)
  203. The development of a postoperative morbidity score to assess total morbidity burden after cardiac surgery
  204. Variation in the uncoupling protein 2 and 3 genes and human performance
  205. Health risks, present and future, from global climate change
  206. Do interest rates matter? Credit demand in the Dhaka slums
  207. The Lichfield bone study: the skeletal response to exercise in healthy young men
  208. Investigating diarrhoea on the ICU: a retrospective study
  209. Relationship between calcaneal quantitative ultrasound and hip dual energy X-ray absorptiometry in young healthy men
  210. Extreme Physiology & Medicine: a new journal focussed on integrative human physiology under stress
  211. Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest
  212. P66 Inter-observer reliability of ultrasound to measure rectus femoris cross-sectional area in critically ill patients
  213. The role of nitrogen oxides in human adaptation to hypoxia
  214. Genetic Influences in Sport and Physical Performance
  215. Sudden exertional death in sickle cell trait: Figure 1
  216. Review article: pancreatic renin-angiotensin systems in health and disease
  217. Cerebral Artery Dilatation Maintains Cerebral Oxygenation at Extreme Altitude and in Acute Hypoxia—An Ultrasound and MRI Study
  218. Normobaric hypoxia impairs human cardiac energetics
  219. The ACE Gene and Human Performance
  220. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery
  221. Climate change, ill health, and conflict
  222. Global health and climate change: moving from denial and catastrophic fatalism to positive action
  223. Association of a sequence variant in DAB2IP with coronary heart disease
  224. A novel ambulatory closed circuit breathing system for use during exercise
  225. Prolongation of the Corrected QT Complex - A Cause of Sudden Cardiac Death in the Mountain Environment?
  226. Tissue Oxygen Saturation and Outcome after Cardiac Surgery
  227. Can Commercially-oriented Microfinance Help Meet the Millennium Development Goals? Evidence from Pakistan
  228. Neuromuscular Blockers and ARDS
  229. Structure to function: muscle failure in critically ill patients
  230. TheACEGene and Performance
  231. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp
  232. Effect of acute hypoxia on QTc interval in respiratory patients undergoing fitness to fly tests
  233. Design and conduct of Caudwell Xtreme Everest: an observational cohort study of variation in human adaptation to progressive environmental hypoxia
  234. Arrhythmias
  235. Natural selection on EPAS1 ( HIF2α ) associated with low hemoglobin concentration in Tibetan highlanders
  236. Caudwell Xtreme Everest Expedition
  237. W56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASE
  238. The Effect of High-Altitude on Human Skeletal Muscle Energetics: 31P-MRS Results from the Caudwell Xtreme Everest Expedition
  239. The anaesthetist and the environment
  240. Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors
  241. A Review of Electrocardiography in the High Altitude Environment
  242. Chapter 1. Introduction
  243. Chapter 2. Surge capacity and infrastructure considerations for mass critical care
  244. Chapter 3. Coordination and collaboration with interface units
  245. Chapter 4. Manpower
  246. Chapter 5. Essential equipment, pharmaceuticals and supplies
  247. Chapter 6. Protection of patients and staff during a pandemic
  248. Chapter 7. Critical care triage
  249. Chapter 8. Medical procedures
  250. Chapter 9. Educational process
  251. Variation in human performance in the hypoxic mountain environment
  252. C-Reactive Protein Gene Variant and the Human Left Ventricular Growth Response to Exercise: Data From the LARGE Heart Study
  253. Angiotensin-converting enzyme and angiotensin II receptor subtype 2 genotypes in type 1 diabetes and severe hypoglycaemia requiring emergency treatment: a case cohort study
  254. DOWN-REGULATION OF ACE EXPRESSION IN HUVECS USING siRNA RESULTS IN DOWN-REGULATION OF UCP2 EXPRESSION: A POTENTIAL MECHANISM OF THE CLINICAL BENEFIT OF ACE-INHIBITORS?
  255. Genetic research and testing in sport and exercise science: A review of the issues
  256. Climate change is not the biggest global health threat – Authors' reply
  257. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes
  258. Climate change: how grave the threat?
  259. Mountain mortality: a review of deaths that occur during recreational activities in the mountains
  260. Managing the health effects of climate change
  261. Higher IL-6 levels but not IL6 −174G>C or −572G>C genotype are associated with post-operative complication following coronary artery bypass graft (CABG) surgery
  262. Arterial Blood Gases and Oxygen Content in Climbers on Mount Everest
  263. Angiotensin-converting enzyme genotype and encephalopathy in Chernobyl cleanup workers
  264. Electrocardiographic (ECG) criteria for determining left ventricular mass in young healthy men; data from the LARGE Heart study
  265. The common G-866A polymorphism of the UCP2 gene and survival in diabetic patients following myocardial infarction
  266. Tissue oxygen saturation during anaesthesia and cardiac surgery, and its association with ICU outcome
  267. Poster Session Abstracts
  268. The effectiveness of bank recapitalization policies in Japan
  269. The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease
  270. The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m)
  271. Angiotensin-converting enzyme genotype may predict survival following major trauma
  272. Physiology of ventilation and gas exchange
  273. Angiotensin-converting enzyme genotype and late respiratory complications of mustard gas exposure
  274. Genetophysiology: Using Genetic Strategies to Explore Hypoxic Adaptation
  275. MALDI LIPID PROFILING - NOVEL APPROACH FOR DETECTION OF DIETARY BASED CHANGES OF PLASMA LIPIDS AND MOLECULAR LIPOPROTEIN MODIFICATIONS
  276. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype
  277. Genetic Variation and Activity of the Renin-Angiotensin System and Severe Hypoglycemia in Type 1 Diabetes
  278. Level of Ex Vivo Interleukin 6 Expression in Human Peripheral Fat Compared with Other Tissues
  279. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease
  280. High Altitude Arrhythmias
  281. Changes in thenar eminence tissue oxygen saturation measured using near-infrared spectroscopy suggest ischaemic preconditioning in a repeated arterial occlusion forearm ischaemia model
  282. Tissue oxygen saturation during anaesthesia, cardiopulmonary bypass and intensive care stay for cardiac surgery
  283. The medical impacts of climate change
  284. Angiotensin-Converting Enzyme Genotype and Successful Ascent to Extreme High Altitude
  285. Genetic Basis of Physical Fitness
  286. The association of left ventricular mass with blood pressure, cigarette smoking and alcohol consumption; data from the LARGE heart study
  287. Impact of genetic factors on outcome from brain injury
  288. ROLE OF BACTERIAL ENDOTOXIN IN CHRONIC HEART FAILURE
  289. Genetic Risk Factors for Subarachnoid Hemorrhage
  290. Angiotensin-Converting Enzyme Genotype Interacts With Systolic Blood Pressure to Determine Coronary Heart Disease Risk in Healthy Middle-Aged Men
  291. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease
  292. Haplotype of growth hormone and angiotensin I-converting enzyme genes, serum angiotensin I-converting enzyme and ventricular growth: pathway inference in pharmacogenetics
  293. Cognitive outcome and cyclo-oxygenase-2 gene (-765 G/C) variation in the preterm infant
  294. Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor
  295. Caudwell Xtreme Everest: a field study of human adaptation to hypoxia
  296. Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training
  297. The Impact of ACE Genotype on Serum ACE Activity in a Black South African Male Population
  298. Left ventricular growth response to exercise and cigarette smoking: data from LARGE Heart
  299. Lack of change in serum angiotensin-converting enzyme activity during the menstrual cycle
  300. Using information technology: engagement modes, flow experience, and personality orientations
  301. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms
  302. +9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease
  303. Glucose-Insulin and Potassium Infusions in Septic Shock
  304. PPARα gene variation and physical performance in Russian athletes
  305. Modalities of Microfinance Delivery in Asia and Latin America: Lessons for China
  306. Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth
  307. The associations of ACE polymorphisms with physical, physiological and skill parameters in adolescents
  308. Assessment of hypoxia in children with cystic fibrosis
  309. Factors affecting a climber’s ability to ascend Mont Blanc
  310. Terrorism and the Medical Response
  311. Variation in the Interleukin-6 Gene Is Associated with Impaired Cognitive Development in Children Born Prematurely: A Preliminary Study
  312. No association between Angiotensin Converting Enzyme (ACE) gene variation and endurance athlete status in Kenyans
  313. ACE Genotype Is Not Associated With Elite Endurance Athlete Status In Kenyans
  314. W13-P-023 Common haplotypes of the IL18 gene and their effect on cardiovascular disease progression following an inflammatory insult
  315. Differentiating explanations of attitude‐consistent behavior: The role of perspectives and mode of perspective taking
  316. The effect of the Basel Accord on bank portfolios in Japan
  317. Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms
  318. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms
  319. Performance at altitude and angiotensin I-converting enzyme genotype
  320. Differentiating in‐group favoritism from shared reality in intergroup perception
  321. Does Interleukin-6 Genotype Influence Cerebral Injury or Developmental Progress After Preterm Birth?
  322. 104 Does Common Variation In The Cylcooxygenase-2 Gene Affect Neuro-Cognitive Outcome after Premature Birth?
  323. Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene
  324. ACE Gene Polymorphism in COPD
  325. ACE Gene Polymorphism in COPD
  326. Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease
  327. IL-6?174G/C genotype is associated with the bone mineral density response to oestrogen replacement therapy in post-menopausal women
  328. Gene-environment interactions and the response to exercise
  329. The ACE gene insertion/deletion polymorphism and elite endurance swimming
  330. Cardiac effects of anabolic steroids
  331. The −344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men
  332. Guanidino Labeling Derivatization Strategy for Global Characterization of Peptide Mixtures by Liquid Chromatography Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
  333. ?Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2
  334. The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype
  335. Bradykinin receptor gene variant and human physical performance
  336. Genetic Variation and Physical Performance
  337. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants
  338. The renin–angiotensin system and physical performance
  339. Current flow patterns in a Faraday disc
  340. Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia
  341. Is Interleukin-6 -174 Genotype Associated With the Development of Septicemia in Preterm Infants?
  342. Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease
  343. Variation in bradykinin receptor genes increases the cardiovascular risk associated with hypertension
  344. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
  345. Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension
  346. Stressing the system
  347. ACE in COPD: a therapeutic target?
  348. Renin–angiotensin systems: the new frontier
  349. Empathy as an Interpersonal Phenomenon
  350. In search of genetic precision
  351. In search of genetic precision
  352. Doctors’ decision processes in a drug-prescription task: The validity of rating scales and think-aloud reports
  353. Cortical bone resorption during exercise is interleukin-6 genotype-dependent
  354. P3458 Inflammatory response to coronary artery bypass surgery: does the Heme-Oxygenase-1 gene microsatellite polymorphism play a role?
  355. General
  356. No association between high-altitude tolerance and the ACE I/D gene polymorphism
  357. Left Ventricular Mass: Reliability of M-Mode and 2-Dimensional Echocardiographic Formulas
  358. Human Performance: A Role for the ACE Genotype?
  359. Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Is Associated with Susceptibility and Outcome in Acute Respiratory Distress Syndrome
  360. Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Arterial Oxygen Saturation at High Altitude
  361. The Gly389Arg beta-1 adrenoceptor polymorphism and cardiovascular disease: time for a rethink in the funding of genetic studies?
  362. Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease?
  363. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  364. Severity of Meningococcal Disease in Children and the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism
  365. ACE Genotype and Performance
  366. Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk
  367. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release
  368. The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers
  369. Peroxisome Proliferator-Activated Receptor alpha Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension
  370. The Effect of Fibrinogen Genotype on Fibrinogen Levels after Strenuous Physical Exercise
  371. Explaining Own and Others' Behavior in a Controversial Issue: Animal Experimentation
  372. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training
  373. Bradykinin B2BKR receptor polymorphism and left-ventricular growth response
  374. The angiotensin converting enzyme I/D polymorphism in Russian athletes
  375. Effect of aCOL1A1Sp1 Binding Site Polymorphism on Arterial Pulse Wave Velocity
  376. Predictive genetics and predictive morphology have certain similarities
  377. Interleukin-6 Gene -174G>C and -572G>C Promoter Polymorphisms Are Strong Predictors of Plasma Interleukin-6 Levels After Coronary Artery Bypass Surgery
  378. Statin therapy and the acute inflammatory response after coronary artery bypass grafting
  379. Angiotensin-Converting Enzyme and Genetics at High Altitude
  380. Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density1
  381. Angiotensin-I Converting Enzyme Genotype-Dependent Benefit from Hormone Replacement Therapy in Isometric Muscle Strength and Bone Mineral Density
  382. Increased QT dispersion with the D-allele of the ACE polymorphism
  383. Elite swimmers and the D allele of the ACE I/D polymorphism
  384. Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism : A Randomized Controlled Trial With Losartan
  385. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women
  386. Genetic Variation and the Response to Exercise
  387. Predisposing Genes, High-Risk Environments and Coronary Artery Disease: LPL and Fibrinogen as Examples
  388. The ACE I/D Polymorphism and Human Physical Performance
  389. Tracking MODIS gain change on-orbit by relating it to SRCA lamp parameters
  390. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6
  391. Gene-environment interactions and the response to exercise
  392. Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload
  393. Raised blood pressure, not renin–angiotensin systems, causes cardiac fibrosis in TGR m(Ren2)27 rats
  394. The genetics of physical fitness
  395. The genetics of critical illness
  396. The algorithm for MODIS wavelength on-orbit calibration using the SRCA
  397. Cardiac reserve: linking physiology and genetics
  398. The ACE gene and muscle performance
  399. <title>Methodology for determining band radiance change under SRCA illumination</title>
  400. Naturalistic Decision Making. (Edited by Zsambok, C. E. and Klein, G.) Lawrence Erlbaum Associates, 1997. 414 pp. ISBN 0-8058-1873-1 (hc), ISBN 0-8058-1874-X (pb).
  401. Human angiotensin I-converting enzyme gene and endurance performance
  402. SRCA radiometric calibration tracking from pre-launch to on-orbit
  403. URINARY INCONTINENCE AND DEPRESSION
  404. Reply from Dr Marko Kerac
  405. Exercise training enhances endothelial function in young men
  406. A Low-Cost Spacer Device
  407. High intensity training and the heart
  408. Double Denial in Attitude Formation1
  409. Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training
  410. Gene-Environment Interaction in the Determination of Levels of Plasma Fibrinogen
  411. Determination of spatial characteristics by using the spectro-radiometric calibration assembly (SRCA) of MODIS: I. Along-scan
  412. Determination of spatial characteristics by using the spectro-radiometric calibration assembly (SRCA) of MODIS: II. Along-track
  413. A Low Cost Spacer Device Used for Asthma Treatment in a Calcutta Street Clinic to Improve Efficacy of Metered Dose Inhalers
  414. Prelaunch algorithm and data format for the Level 1 calibration products for the EOS-AM1 Moderate Resolution Imaging Spectroradiometer (MODIS)
  415. Daily patterns of secretion of neurohypophysial hormones in man: effect of age
  416. Human gene for physical performance
  417. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27
  418. Compatibility and the use of information processing strategies
  419. Association of Angiotensin-Converting Enzyme Gene I/D Polymorphism With Change in Left Ventricular Mass in Response to Physical Training
  420. Should the contribution of ACE gene polymorphism to left ventricular hypertrophy be reconsidered?
  421. Gene-environment interaction in the determination of plasma levels of fibrinogen
  422. 3,4-methylenedioxymethamphetamine (MDMA, or “ecstasy”) and associated hypoglycemia
  423. Gene-Environment Interaction in the Determination of Levels of Haemostatic Variables Involved in Thrombosis and Fibrinolysis
  424. 16. Gene-environment interaction in the determination of plasma fibrinogen levels
  425. MODIS Calibration: A Brief Review of the Strategy for the At-Launch Calibration Approach
  426. The Acute Rise in Plasma Fibrinogen Concentration With Exercise Is Influenced by the G-453-A Polymorphism of the  -Fibrinogen Gene
  427. Gene-environment interaction in coronary artery disease (CAD)
  428. Drug points: Rhabdomyolysis and multiple system organ failure with streptokinase
  429. Pulmonary embolism as a cause of pulmonary oedema
  430. Heparin in unstable angina
  431. Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy
  432. Interpretation of electrocardiograms by doctors
  433. Violations of procedure invariance in preference measurement: Cognitive explanations
  434. Towards a perspective theory of decision making and judgment
  435. Salicylate intoxication causing a severe systemic inflammatory response and rhabdomyolysis
  436. Unsuspected coronary artery disease revealed by administration of nebulised salbutamol.
  437. The judgment-choice discrepancy: Noncompatibility or restructuring?
  438. Magnesium and myocardial infarction
  439. Thrombolytic Therapy for Myocardial Infarction
  440. Perception: The interface between cognition and the external world
  441. Cerebral mass lesions in patients with AIDS.
  442. Letter to the editor
  443. Mental models and problem solving: Three challenges to a theory of restructuring and insight
  444. Magnitude scales, category scales, and the general psychophysical differential equation
  445. Giant Basal Cell Carcinoma
  446. Direct estimation: effect of methodological factors on scale tupe
  447. The 1974 Fields Medals (II): An Analyst and Number Theorist
  448. Is an equal interval scale an equal discriminability scale?
  449. 11.—The Symmetry of Atomic Vibrations in KH2PO4
  450. The symmetry of crystal vibrations in solid CO2
  451. Losing the Peace: Georgia Republicans and Reconstruction, 1865-1871.
  452. The symmetry of lattice vibrations in the zincblende and diamond structures
  453. The Emergence of the New South, 1913-1945
  454. INFLUENCE OF NICOTINE ON THE BLOOD FLOW OF RESTING SKELETAL MUSCLE AND OF THE DIGITS IN NORMAL SUBJECTS*
  455. EFFECTS OF SMOKING IN DISEASES OF THE PERIPHERAL VASCULAR SYSTEM
  456. Use of oral hypoglycemic agents in the treatment of brittle and poorly controlled diabetes mellitus
  457. THE USE OF CHLORPROPAMIDE IN BRITTLE AND POORLY CONTROLLED DIABETES MELLITUS
  458. Smooth-Muscle Tumors of the Skin
  459. Keratoacanthoma Versus Squamous-Cell Carcinoma
  460. Influence of an Oscillating Bed on Cutaneous Temperature and Oxygen Tension of Ischemic Toes
  461. Reticulohistiocytoma (Reticulohistiocytic Granuloma)
  462. Oxygen tension of peripheral tissue
  463. ASIATIC INFLUENZA IN THE MIDDLE EAST AN OUTBREAK IN A SMALL COMMUNITY
  464. Melanotic Whitlow (Subungual Melanoma)1
  465. A Method of Exhibiting Lantern Slides on X-Ray View Boxes
  466. Polariscopic and Histochemical Studies in Angiokeratoma Corporis Diffusum
  467. Fox-Fordyce Disease in the Male
  468. Histopathology of Cutaneous Lesions in Systemic Lupus Erythematosus
  469. Evaluation of Cutaneous Smears in Lymphoblastomas of the Skin
  470. Fox - Fordyce Disease
  471. RINGED HAIR
  472. Histopathology of Porphyria Cutanea Tarda12
  473. The Senile Nail11Read at the meeting of the Society for Investigative Dermatology, San Francisco, California, June 19, 1954.
  474. Clinical Study and Treatment of Varicose Veins
  475. Blue Nevus and Its Distinction from Mongolian Spot and the Nevus of Ota*†‡
  476. Experimental Immersion Foot. I. The Effects of Prolonged Exposure to Water at 3° C. on the Oxygen Tension AND Temperature of the Rabbit Leg1
  477. Experimental Immersion Foot. II. Functional and Histological Changes in the Rabbit Leg Exposed to Water at 3°C., and Therapeutic Trial of Cortisone and of Inhaled Oxygen1
  478. Pathogenesis of Generalized Dermal Pigmentation Secondary to Malignant Melanoma and Melanuria*
  479. Experimental Immersion Foot. Review of the Physiopathology
  480. Pemphigus and Other Bullous Dermatoses: Correlation of Clinical and Pathologic Findings1
  481. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. VI. EFFECT OF CHANGES IN POSITION ON OXYGEN TENSION OF THE SKIN OF TOES 1
  482. The Effect of Cold Stress, Acth, Cortisone, Pyrogen, and Nitrogen Mustard on Tissue Mast Cells in the Skin and Subcutaneous Tissues of the Rat12
  483. Histopathologic Studies of Pigmented Nevi in Children*†
  484. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. V. THE RATE OF MOVEMENT OF OXYGEN FROM THE PERIPHERAL ARTERY TO THE SKIN 1
  485. BENIGN AND MALIGNANT DERMAL NEOPLASMS
  486. THE VASODILATOR EFFECTS OF INTRAVENOUS PROCAINE IN PATIENTS WITH ISCHEMIC EXTREMITIES
  487. HUMAN MELANOGENESIS: CYTOLOGY AND HISTOLOGY OF PIGMENT CELLS (MELANODENDROCYTES)
  488. SQUAMOUS-CELL EPITHELIOMA THAT SIMULATES SARCOMA
  489. Oxygen Tension of Tissues by the Polarographic Method
  490. MULTIPLE GLOMUS TUMORS
  491. Oxygen Tension of Tissues by the Polarographic Method
  492. OXYGEN TENSION OF TISSUES BY THE POLAROGRAPHIC METHOD. I. INTRODUCTION: OXYGEN TENSION AND BLOOD FLOW OF THE SKIN OF HUMAN EXTREMITIES
  493. Tyrosinase in Human Skin: Demonstration of Its Presence and of Its Role in Human Melanin Formation
  494. CUTANEOUS CHANGES IN LUPUS ERYTHEMATOSUS
  495. EFFECTS OF VASODILATOR DRUGS AND OTHER PROCEDURES ON DIGITAL CUTANEOUS BLOOD FLOW, CARDIAC OUTPUT, BLOOD PRESSURE, PULSE RATE, BODY TEMPERATURE, AND METABOLIC RATE
  496. HEREDITARY ANHIDROTIC ECTODERMAL DYSPLASIA
  497. DISSEMINATE LUPUS ERYTHEMATOSUS
  498. NODULAR SUBEPIDERMAL FIBROSIS (DERMATOFIBROMA VERSUS HISTIOCYTOMA)
  499. Psoriasis and Mycosis Fungoides Occurring in the same Patient, Both Conditions Proved Histologically
  500. The Arterioles of the Skin in Essential Hypertension1,21Read before the Eighth Annual Meeting of the Society for Investigative Dermatology, Atlantic City, New Jersey, June 10, 1947.2Abridgment of thesis submitted by Dr. Farber to the Faculty of the Gra...
  501. STUDIES IN RHEUMATIC FEVER II. ABSORPTION OF SALICYLATES
  502. STUDIES IN RHEUMATIC FEVER
  503. NODULAR VASCULAR DISEASES OF THE LEGS
  504. CUTANEOUS TUMORS OF VON RECKLINGHAUSEN'S DISEASE (NEUROFIBROMATOSIS)
  505. ACRODERMATITIS ATROPHICANS CHRONICA
  506. PEPTIC ULCER, GASTRITIS AND PSYCHONEUROSIS
  507. DERMATOLOGIC SIGNIFICANCE OF TISSUE EOSINOPHILIA
  508. HISTOPATHOLOGIC STUDY OF PSORIASIS
  509. EPITHELIAL CYSTS
  510. PARAPSORIASIS: ITS RELATION TO MYCOSIS FUNGOIDES AND TUBERCULOSIS
  511. GRANULOMA ANNULARE
  512. THE EFFECT OF DRUGS ON THE CIRCULATION IN NORMAL HANDS AND FEET
  513. Lumbar sympathectomy in the treatment of intermittent claudication
  514. VERRUCA PLANA AND EPITHELIAL NEVUS
  515. ARGYRIA
  516. TYPES OF ORTHOSTATIC HYPOTENSION AND THEIR TREATMENT
  517. The significance of diagnostic tests in the study of peripheral vascular disease
  518. USE OF ACETYL-BETA-METHYLCHOLINE CHLORIDE IONTOPHORESIS IN NON-ARTERIAL PERIPHERAL VASCULAR DISEASE
  519. LICHEN SCLEROSUS ET ATROPHICUS
  520. NECROBIOSIS LIPOIDICA DIABETICORUM
  521. METASTASIS OF CARCINOMA TO THE SCALP
  522. V. CUTANEOUS XANTHOMATOSIS
  523. DERMATITIS OF THE EAR
  524. FOUR PHYSIOTHERAPEUTIC DEVICES FOR THE TREATMENT OF PERIPHERAL VASCULAR DISORDERS
  525. PRECANCEROUS DERMATOSIS AND EPITHELIOMA IN SITU
  526. VALUE AND LIMITATIONS OF BIOPSY IN DERMATOLOGY
  527. THE EFFECT OF IONTOPHORESES WITH ACETYL-BETA-METHYLCHOLINE CHOLRIDE ON THE RATE OF PERIPHERAL BLOOD FLOW
  528. THE EFFECTS OF PRESSOR DRUGS AND OF SALINE KIDNEY EXTRACTS ON BLOOD PRESSURE AND SKIN TEMPERATURE 1
  529. XANTHOMATOSIS
  530. CHRONIC ROENTGEN AND RADIUM DERMATITIS
  531. ACNE NECROTICA MILIARIS OF THE SCALP
  532. MONOCYTIC LEUKEMIA
  533. HISTOPATHOLOGY OF VARIOUS TYPES OF CUTANEOUS TUBERCULOSIS
  534. THE SITE OF ACIDIFICATION OF THE URINE WITHIN THE RENAL TUBULE IN AMPHIBIA
  535. ANGIOMA SERPIGINOSUM
  536. ARSENIC AS AN ETIOLOGIC AGENT IN CERTAIN TYPES OF EPITHELIOMA
  537. KRAUROSIS, LEUKOPLAKIA AND PRURITUS VULVAE
  538. MULTIPLE GANGLIONEUROMAS OF THE SKIN
  539. EXFOLIATIVE DERMATOSIS AND MALIGNANT ERYTHRODERMA
  540. RESECTION OF SENSORY NERVES OF PERINEUM IN CERTAIN IRRITATIVE CONDITIONS OF THE EXTERNAL GENITALIA
  541. XANTHOMA MULTIPLEX
  542. Verruca senilis und Keratoma senile
  543. XERODERMA PIGMENTOSUM
  544. LUPUS ERYTHEMATOSUS
  545. CUTANEOUS LYMPHOBLASTOMA
  546. Schweißdrüsentumor mit Epithelmetaplasie
  547. LARVA MIGRANS (CREEPING ERUPTION)
  548. PIGMENTATION OF THE SKIN IN ADDISON'S DISEASE, ACANTHOSIS NIGRICANS AND HEMOCHROMATOSIS
  549. THE COPPER CONTENT AND THE MINIMAL MOLECULAR WEIGHT OF THE HEMOCYANINS OF BUSYCON CANALICULATUM AND OF LOLIGO PEALEI
  550. SUPERFICIAL EPITHELIOMATOSIS
  551. BASAL SQUAMOUS CELL EPITHELIOMA
  552. Kotwinski, PJ; Smith, G; Cooper, J; Sanders, J; Ma, L; Teis, A; Kotwinski, D; (2016) BETTER-CARE_Paper1. [Dataset]. Centre for Human Health and Performance, Institute for Sport Exercise and Health, University College London: London, UK